SRF Ltd. Stock Skyrockets 4% on Major Analyst Upgrade: Chemical Growth Poised for Big Jump!

CHEMICALS
Whalesbook Logo
AuthorAbhay Singh|Published at:
SRF Ltd. Stock Skyrockets 4% on Major Analyst Upgrade: Chemical Growth Poised for Big Jump!
Overview

Axis Capital has upgraded SRF Limited to 'Buy', sending its shares up over 4%. The brokerage forecasts a strong 23% CAGR for the chemical business until FY28, driven by specialty chemicals and new products. While price targets were slightly adjusted, the upgrade signals positive sentiment for SRF's core growth segments.

Axis Capital has upgraded SRF Limited to a 'Buy' rating from its previous 'Add' recommendation, leading to a significant rise in the company's share price. The brokerage also revised its price target for the stock, setting it at ₹3,330 per share, down from the earlier ₹3,410.

Analyst Opinions

  • Axis Capital's upgrade to 'Buy' highlights increased confidence in SRF Limited's future performance.
  • The revised price target of ₹3,330 suggests a potential upside, though slightly lower than the previous target.
  • The upgrade is primarily underpinned by the strong growth prospects identified in the company's chemical business segment.

Key Numbers or Data

  • SRF Limited's shares traded over 4% higher on Friday.
  • The chemical business is expected to achieve a Compound Annual Growth Rate (CAGR) of 23% from FY25 to FY28.
  • Specialty chemicals are projected to grow at a remarkable 26% CAGR.
  • EBITDA estimates for FY26 to FY28 have been reduced by 3-7% due to margin expectations in commodity businesses.

Future Expectations

  • Growth in the specialty chemicals division is anticipated to be fueled by the ramp-up of active ingredients (AIs) and the introduction of new molecules, alongside increased sales of existing products.
  • Pricing in the chemical segment is expected to remain largely stable, providing a predictable revenue stream.
  • The refrigerant gas business is forecast to benefit from optimal utilization of R32 capacity and a price increase, supported by rising prices in China, which could improve margins.

Market Reaction

  • SRF Limited's stock saw a notable increase in trading volume and price following the analyst upgrade.
  • The stock was trading approximately 2.51% higher at ₹2,911.20 at the time of the report.
  • Year-to-date, SRF's stock has appreciated by approximately 32% in 2025, indicating strong investor interest.

Risks or Concerns

  • Axis Capital noted that the recovery in earnings for the packaging films and technical textiles divisions might take longer than anticipated.
  • The reduction in EBITDA estimates reflects potential margin pressures in the company's commodity-related businesses.

Impact

  • The analyst upgrade is likely to bolster investor confidence in SRF Limited and support its stock price in the short to medium term.
  • Investors will be closely watching the execution of growth strategies in the chemical segment.
  • Impact Rating: 7/10

Difficult Terms Explained

  • CAGR: Compound Annual Growth Rate, representing the average annual growth rate of an investment over a specified period longer than one year.
  • EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization, a key metric reflecting a company's operational profitability.
  • AIs: Active Ingredients, the primary components in chemical products or pharmaceuticals responsible for their intended effect.
  • R32: Difluoromethane, a widely used refrigerant gas in air conditioning and refrigeration systems.
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.